![HHS’ Proposed New Anti-Discrimination Rule & What You Can Do to Comply with It](https://www.g2intelligence.com/wp-content/uploads/2022/09/Oct22.NLR_.HHSAntiDiscrimRule-iStock-1800x1250-1-1080x675.jpg)
HHS’ Proposed New Anti-Discrimination Rule & What You Can Do to Comply with It
What you need to know about the 308-page proposed rule and its potential impact on your lab, along with a basic strategy to implement it.
What you need to know about the 308-page proposed rule and its potential impact on your lab, along with a basic strategy to implement it.
The problems began in January 2020 when hackers got access to an employee’s email account, compromising clients’ personal data.
The agency recently announced subtle but significant changes to its policies governing review of new lab tests for COVID-19.
Learn more about how leveraging data automation to get clean patient data at the front end can be a game changer for labs.
The CDRH Total Product Life Cycle Advisory Program Pilot aims to improve the FDA authorization process for medical devices.
The new deal provides the FDA a minimum of $1.78 billion in user fees from 2023 to 2027.
In this week’s enforcement roundup, Radeas reaches a settlement with the State of North Carolina after alleged improper billing.
Judge Edward Davila postponed sentencing for at least one month to consider new evidence of possible government misconduct.
Learn more about the legal remedies potentially available to clinical labs who have not been fully paid for COVID testing by insurers.
Learn about how the COVID-19 pandemic has shaped the clinical lab industry and how those lessons can lead to better labs for the future.